Munafa Stock Market Course + Intraday & FNO calls 
Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 17 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 281.86 and Closed at: 267.46, which is -5.8% of previous session's close. It moved within a range of 266.43 and 284.36
The session was a Bearish session with an average volume of 762876, which is -17.99% of previous session's volumes.
- There is some negative change in the short term trend, but its too soon to jump onto conclusions.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 257.98 and resistance for tomorrow is 275.91
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 261.14, 254.82 resistance for tomorrow's hourly charts is 279.07, 290.68
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 296.86 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 295.44 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 294.27 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 306.25 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 359.11 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 295.44 and 200 DMA is at 359.11, while 50 DMA and 100 DMA are at 294.27 and 306.25 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 295.44 and 20 EMA is at 292.96
| Date | Closing Price | 20 SMA | 20 EMA |
| 17 Fri Jul | 267.46 | 295.44 | 292.96 |
| 16 Thu Jul | 282.98 | 296.2 | 295.64 |
| 15 Wed Jul | 279.14 | 296.15 | 296.97 |
| 14 Tue Jul | 281.31 | 296.58 | 298.85 |
| 13 Mon Jul | 288.06 | 296.66 | 300.7 |
| 10 Fri Jul | 298.76 | 296.73 | 302.03 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 294.27 and 50 EMA is at 297.78
| Date | Closing Price | 50 SMA | 50 EMA |
| 17 Fri Jul | 267.46 | 294.27 | 297.78 |
| 16 Thu Jul | 282.98 | 294.98 | 299.02 |
| 15 Wed Jul | 279.14 | 295.34 | 299.67 |
| 14 Tue Jul | 281.31 | 295.72 | 300.51 |
| 13 Mon Jul | 288.06 | 296.02 | 301.29 |
| 10 Fri Jul | 298.76 | 296.44 | 301.83 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 306.25 and 100 EMA is at 311.61
| Date | Closing Price | 100 SMA | 100 EMA |
| 17 Fri Jul | 267.46 | 306.25 | 311.61 |
| 16 Thu Jul | 282.98 | 306.94 | 312.5 |
| 15 Wed Jul | 279.14 | 307.5 | 313.1 |
| 14 Tue Jul | 281.31 | 308.04 | 313.79 |
| 13 Mon Jul | 288.06 | 308.55 | 314.45 |
| 10 Fri Jul | 298.76 | 308.81 | 314.98 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 359.11 and 200 EMA is at 325.73
| Date | Closing Price | 200 SMA | 200 EMA |
| 17 Fri Jul | 267.46 | 359.11 | 325.73 |
| 16 Thu Jul | 282.98 | 360.01 | 326.32 |
| 15 Wed Jul | 279.14 | 360.83 | 326.76 |
| 14 Tue Jul | 281.31 | 361.68 | 327.24 |
| 13 Mon Jul | 288.06 | 362.57 | 327.7 |
| 10 Fri Jul | 298.76 | 363.4 | 328.1 |
Novo Nordisk has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Novo Nordisk, about 20.31% more returns!
Merck Company has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Merck Company, about 15.76% more returns!
Encompass Health has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Encompass Health, about 18.28% more returns!
Alnylam Pharmaceuticals has performed better than Riot Blockchain in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Radnet Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 19.54% more returns!
Alnylam Pharmaceuticals has performed better than Proqr Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Phio Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 4.79% more returns!
Pacira Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 18.51% more returns!
Puma Biotechnology has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Puma Biotechnology, about 16.65% more returns!
Marker Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Marker Therapeutics, about 2.32% more returns!
Luminex Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Luminex Corporation, about 26.58% more returns!
Henry Schein has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 13.7% more returns!
Alnylam Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Caredx Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 55.58% more returns!
Alnylam Pharmaceuticals has performed better than Bioxcel Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Biolife Solutions has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Biolife Solutions, about 15.76% more returns!
Alnylam Pharmaceuticals has performed better than Ardelyx Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Aclaris Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 30.04% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Alnylam Pharmaceuticals in short term and the sell signal is strong.
Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 297.52 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
